Retention of Endogenous Viable Cells Enhances the Anti-Inflammatory Activity of Cryopreserved Amnion

Objective: Human amniotic membrane (hAM) has been used to treat wounds for more than 100 years. However, widespread use of fresh hAM has been limited due to its short shelf life and safety concerns. To overcome these concerns, different preservation methods have been introduced. The majority of thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan-Arnold, Yi, Gyurdieva, Alexandra, Johnson, Amy, Uveges, Thomas E., Jacobstein, Douglas A., Danilkovitch, Alla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Forum Theme: Placental Membrane TherapeuticsForum Editor: Alla DanilkovitchDiscovery Express
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529089/
https://www.ncbi.nlm.nih.gov/pubmed/26401419
http://dx.doi.org/10.1089/wound.2015.0636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529089/
https://www.ncbi.nlm.nih.gov/pubmed/26401419
http://dx.doi.org/10.1089/wound.2015.0636

Ejemplares similares